Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Netomi today announced $110 million in new funding led by Accenture Ventures, with participation from Adobe Ventures, WndrCo, SLW, NAVER Ventures, Metis Strategy, and Fin Capital. This round builds on early investments from AI pioneers Greg Brockman, Demis Hassabis, and Mustafa Suleyman. Netomi is the enterprise agentic CX platform built for the highest-stakes environments — operating at massive scale, under regulatory oversight, where failure is not an option. D...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global medtech leader, today reported results for the first quarter of 2026. “Financial results for the quarter overall were in line with our expectations, and we are making progress to stabilize the business, embed a culture of continuous improvement, and strengthen execution,” said Andrew Hider, president and CEO. “Although more work remains to achieve our full potential, Baxter continues to take the decisive steps nec...

NEW YORK--(BUSINESS WIRE)--Accenture has made an investment, through Accenture Ventures, in Netomi, a leading customer experience AI platform company....

LONDON--(BUSINESS WIRE)--  Xtrackers Investment Company with Variable Capital Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) Important Notice to the Shareholders of Xtrackers MSCI EM Latin America ESG Swap UCITS ETF 1C (ISIN: LU0292108619) Xtrackers MSCI Europe Materials Screened UCITS ETF 1C (ISIN: LU0292100806) Xtrackers MSCI Europe Health Care Screened UCITS ETF 1C (ISIN: LU0292103222) Xtrackers MSCI Europe Financials Screened UCITS...

ST. LOUIS--(BUSINESS WIRE)--Belden Inc. (NYSE: BDC) (“Belden” or the “Company”), a leading global supplier of specialty networking solutions, today reported fiscal first quarter results for the period ended March 29, 2026. First Quarter 2026 Highlights Revenues of $696 million, up 11% y/y and up 7% y/y organically GAAP EPS of $1.30, up 2% y/y Adjusted EPS of $1.77, up 11% y/y Repurchased 0.3 million shares for $30 million during the quarter "Belden delivered a strong start to 2026, with revenue...

RICHARDSON, Texas--(BUSINESS WIRE)--Vistance Networks, Inc. (NASDAQ: VISN), a leading provider of intelligent network solutions, reported results for the quarter ended March 31, 2026....

LONDON--(BUSINESS WIRE)--  Xtrackers Investment Company with Variable Capital Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) Important Notice to the Shareholders of Xtrackers MSCI EM Latin America ESG Swap UCITS ETF 1C (ISIN: LU0292108619) Xtrackers MSCI Europe Materials Screened UCITS ETF 1C (ISIN: LU0292100806) Xtrackers MSCI Europe Health Care Screened UCITS ETF 1C (ISIN: LU0292103222) Xtrackers MSCI Europe Financials Screened UCITS...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: City of London Investment Management Company Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it will publish financial results for the first quarter 2026 and provide a business update on May 5, 2026. About Precision BioSciences, Inc. Precision BioSciences, Inc. is a clinical stage gene editing company dedicated to improving life (DTIL)...

BILLERICA, Mass.--(BUSINESS WIRE)--Entegris, Inc. (NASDAQ: ENTG), a leading supplier of critical advanced materials and process solutions for the semiconductor and other high-technology industries, today announced the appointment of Sukhi Nagesh as the Company’s Chief Financial Officer (“CFO”), effective May 18, 2026. Mr. Nagesh has nearly 30 years of leadership experience in finance, investor relations, and corporate strategy and development roles at semiconductor and technology companies. He...